Obeldesivir provided faster symptom relief but did not reduce hospitalization or all-cause mortality in high-risk nonhospitalized patients with COVID-19.

Messenger RNA, or mRNA – a technology that can instruct cells to fight disease – has fueled breakthroughs from Covid vaccines ...

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...

The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...

According to the Cleveland Clinic, an American nonprofit academic medical centre, an mRNA vaccine trains your body to fight ...

Both public and private funding have plummeted as federal policy changes have thrown the biotech sector into an era of ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

A study of over 10,000 nasal swabs finds that recent rhinovirus infections, the main cause of the common cold, reduce the ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

Research shows COVID-19 accelerates vascular aging, especially in women, with implications for long-term cardiovascular ...

Researchers discovered viral fragments in blood samples from long COVID patients, hinting at a possible biomarker. The ...

From the Human Genome Project to large-scale initiatives like the UK Biobank and The Cancer Genome Atlas (TCGA), the recent ...